Haemotology Flashcards
1
Q
Coagulation cascade:
A
- Prothrombin to thrombin
- Thrombin changes fibrinogen to fibrin
- Causes the cross-linked fibrin coat
2
Q
Two pathways of the coagulation cascade:
A
- Intrinsic: important for amplification more than initiation
- extrinsic: important for initiation, triggered by release of tissue factor from damaged tissue
3
Q
4 components of clotting:
A
- Vascular response - vasoconstriction
- Platelet plug formation
- Fibrin plug - intrinsic and extrinsic pathway
- Lysis of clot
4
Q
Objective assessment:
A
- Lymph node assessment
- Palpate liver and spleen
- Skin
- Eyes, mouth
- Neurological
- Vital signs
5
Q
Full Blood Count components:
A
- Haemoglobin
- Haematocrit (packed cells)
- White cell count
- Erythrocyte sedimentation rate
- Platelets
- Other: blood typing, Rh factor, iron metabolism
6
Q
Cause of low Hb:
A
- inadequate production of RBC
- inadequate iron intake
- inadequate folate/vitamin B12
- microscopic bleeding/blood loss
- blood cell destruction
- chronic illness
- defect in Hb molecule
7
Q
Haematocrit:
A
- percentage of packed RBC in a whole blood sample
- influenced by absolute number of cells, but also average size of cells
8
Q
erythrocyte sedimentation rate:
A
- time needed for the RBCs in a whole blood sample to settle to the bottom
9
Q
International Normalised Ratio (INR)
A
- measure of how long it takes for blood to clot
- target INR different for different conditions (eg. AF 2-3seconds)
- higher INR recommended for mechanical heart valve or irregular clotting conditions.
10
Q
Diagnostics:
A
- Full Blood Count
- Coagulation panel (PT, INR, APTT)
- Liver function tests
- Platelet count
- ESR
- Fibrinogen
- Iron studies
- Stool for hemoccult blood
11
Q
Low Molecular Weight Heparin (LMWH)
A
- 100-750 times smaller than heparin
- greater SC availability and longer half-life
- fewer adverse effects
- eg. Clexane (enoxaparin)
12
Q
Prophylactic vs analgesic aspirin doses:
A
- Prophylactic (platelet coagulation): 100-150mg
- Analgesic/anti-inflammatory effect: 300-600mg
13
Q
Lymphoma
A
Malignancy of lymphocytes that begins in lymph nodes.
- Hodgkins (more common in young and male)
- Non-Hodgkins (90% of lymphomas, B cell (CLL & SLL)
14
Q
Lymphoma risk factors:
A
- Radiation exposure
- Weakened immune system (immunosuppressants, genetics)
- more common in people with autoimmune diseases
- caused by infection (eg. helicobacter pylori, HTLV-1)
- exposure to chemicals/drugs (eg. benzene, herbicides, insecticides)
- chemotherapy
15
Q
Diagnosis of lymphoma:
A
- symptoms (eg. fatigue, infection, lymph node enlargement
- biopsy
- blood smear - morphology
- blood counts
- immunophenotypic markers